Dr. Gloria Delfanti is a postdoctoral fellow in the Experimental Immunology Unit at San Raffaele Scientific Institute (Milan, Italy), led by Dr. Giulia Casorati and Dr. Paolo Dellabona. Her research focuses on engineering invariant Natural Killer T (iNKT) cells with chimeric antigen receptors and pro-inflammatory cytokines to advance next-generation cancer immunotherapies for aggressive and metastatic cancers.